Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence
Janet K. Coller, Mark R. Hutchinson
Pharmacology & Therapeutics (2012) Vol. 134, Iss. 2, pp. 219-245
Closed Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Early-Life Adversity and Physical and Emotional Health Across the Lifespan: A Neuroimmune Network Hypothesis
Robin Nusslock, Gregory E. Miller
Biological Psychiatry (2015) Vol. 80, Iss. 1, pp. 23-32
Open Access | Times Cited: 585
Opioid Activation of Toll-Like Receptor 4 Contributes to Drug Reinforcement
Mark R. Hutchinson, Alexis L. Northcutt, Takato Hiranita, et al.
Journal of Neuroscience (2012) Vol. 32, Iss. 33, pp. 11187-11200
Open Access | Times Cited: 270
High Mobility Group Box 1/Toll-like Receptor Danger Signaling Increases Brain Neuroimmune Activation in Alcohol Dependence
Fulton T. Crews, Liya Qin, Donna Sheedy, et al.
Biological Psychiatry (2012) Vol. 73, Iss. 7, pp. 602-612
Open Access | Times Cited: 270
Glial and Neuroimmune Mechanisms as Critical Modulators of Drug Use and Abuse
Michael J. Lacagnina, Phillip D. Rivera, Staci D. Bilbo
Neuropsychopharmacology (2016) Vol. 42, Iss. 1, pp. 156-177
Open Access | Times Cited: 235
Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease
Stephanie Matt, Peter J. Gaskill
Journal of Neuroimmune Pharmacology (2019) Vol. 15, Iss. 1, pp. 114-164
Open Access | Times Cited: 212
Pain and Poppies: The Good, the Bad, and the Ugly of Opioid Analgesics
Tuan Trang, Ream Al‐Hasani, Daniela Salvemini, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 41, pp. 13879-13888
Open Access | Times Cited: 201
DAT isn’t all that: cocaine reward and reinforcement require Toll-like receptor 4 signaling
Alexis L. Northcutt, Mark R. Hutchinson, Xiaohui Wang, et al.
Molecular Psychiatry (2015) Vol. 20, Iss. 12, pp. 1525-1537
Open Access | Times Cited: 201
Consequences of adolescent drug use
Michael Steinfeld, Mary M. Torregrossa
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 153
Neuroimmune signaling: a key component of alcohol abuse
Jody Mayfield, Laura B. Ferguson, R. Adron Harris
Current Opinion in Neurobiology (2013) Vol. 23, Iss. 4, pp. 513-520
Open Access | Times Cited: 181
Neuroimmune Mechanisms of Alcohol and Drug Addiction
Changhai Cui, David Shurtleff, R. Adron Harris
International review of neurobiology (2014), pp. 1-12
Open Access | Times Cited: 152
Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4
Xiaohui Wang, Yu Zhang, Yinghua Peng, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 5, pp. 856-869
Open Access | Times Cited: 148
TLR4 elimination prevents synaptic and myelin alterations and long-term cognitive dysfunctions in adolescent mice with intermittent ethanol treatment
Jorge Montesinos, María Pascual, Antoni Pla, et al.
Brain Behavior and Immunity (2014) Vol. 45, pp. 233-244
Closed Access | Times Cited: 132
Effect of Chronic Delivery of the Toll-like Receptor 4 Antagonist (+)-Naltrexone on Incubation of Heroin Craving
Florence Theberge, Xuan Li, Sarita Kambhampati, et al.
Biological Psychiatry (2013) Vol. 73, Iss. 8, pp. 729-737
Open Access | Times Cited: 120
Microbiota‐gut‐brain axis as a regulator of reward processes
Rubén García‐Cabrerizo, Carina Carbia, Kenneth J. O ́Riordan, et al.
Journal of Neurochemistry (2020) Vol. 157, Iss. 5, pp. 1495-1524
Closed Access | Times Cited: 106
Prenatal opioid exposure: The next neonatal neuroinflammatory disease
Lauren L. Jantzie, Jessie R. Maxwell, Jessie Newville, et al.
Brain Behavior and Immunity (2019) Vol. 84, pp. 45-58
Open Access | Times Cited: 99
Cannabis exposure as an interactive cardiovascular risk factor and accelerant of organismal ageing: a longitudinal study
Albert Stuart Reece, Amanda Norman, Gary Kenneth Hulse
BMJ Open (2016) Vol. 6, Iss. 11, pp. e011891-e011891
Open Access | Times Cited: 97
Plasma profile of pro‐inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co‐morbidity
Pedro Araos, María Pedraz, Antonia Serrano, et al.
Addiction Biology (2014) Vol. 20, Iss. 4, pp. 756-772
Closed Access | Times Cited: 96
Neuroendocrine-immune interaction: Evolutionarily conserved mechanisms that maintain allostasis in an ever-changing environment
B.M.L. Verburg-van Kemenade, Nicholas Cohen, Magdalena Chadzińska
Developmental & Comparative Immunology (2016) Vol. 66, pp. 2-23
Closed Access | Times Cited: 90
Toll-Like Receptor Signaling in Depression
Leandra K. Figueroa‐Hall, Martin P. Paulus, Jonathan Savitz
Psychoneuroendocrinology (2020) Vol. 121, pp. 104843-104843
Open Access | Times Cited: 88
The Crosstalk Between Neurons and Glia in Methamphetamine-Induced Neuroinflammation
Sai Shi, Tianzhen Chen, Min Zhao
Neurochemical Research (2022) Vol. 47, Iss. 4, pp. 872-884
Closed Access | Times Cited: 41
Annual Research Review: Neuroimmune network model of depression: a developmental perspective
Robin Nusslock, Lauren B. Alloy, Gene H. Brody, et al.
Journal of Child Psychology and Psychiatry (2024) Vol. 65, Iss. 4, pp. 538-567
Open Access | Times Cited: 10
The interaction between central and peripheral immune systems in methamphetamine use disorder: current status and future directions
Sai Shi, Yiwen Sun, Gui‐Ying Zan, et al.
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Why is neuroimmunopharmacology crucial for the future of addiction research?
Mark R. Hutchinson, Linda R. Watkins
Neuropharmacology (2013) Vol. 76, pp. 218-227
Open Access | Times Cited: 94
Structure–Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists
Brandon R. Selfridge, Xiaohui Wang, Yingning Zhang, et al.
Journal of Medicinal Chemistry (2015) Vol. 58, Iss. 12, pp. 5038-5052
Open Access | Times Cited: 85
Glial Modulators as Potential Treatments of Psychostimulant Abuse
Patrick M. Beardsley, Kurt F. Hauser
Advances in pharmacology (2014), pp. 1-69
Open Access | Times Cited: 80
Page 1 - Next Page

Scroll to top